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OBJECTIVES To evaluate the incidence of, and risk factors for, complications of endomyocardial biopsy in
children.
BACKGROUND Endomyocardial biopsy (EMB) is a low risk procedure in adults, but there is a paucity of data
with regard to performing this procedure in children.
METHODS Retrospective review of the morbidity and mortality of 1,000 consecutive EMB procedures.
RESULTS One thousand EMB procedures (right ventricle 986, left ventricle 14) were performed on 194
patients from July 1987 through March 1996. Indications for EMB included heart transplant
rejection surveillance (846) and the evaluation of cardiomyopathy or arrhythmia for possible
myocarditis (154). Thirty-seven (4%) procedures were performed on patients receiving
intravenous inotropic support. There was one biopsy related death, secondary to cardiac
perforation, in a two-week-old infant with dilated cardiomyopathy. There were nine
perforations of the right ventricle, eight occurring in patients with dilated cardiomyopathy
and one in a transplant recipient. The transplant patient did not require immediate
intervention; two patients required pericardiocentesis alone, and six underwent pericardio-
centesis and surgical intervention. All nine perforations were from the femoral venous
approach (p , 0.01). Multivariate analysis demonstrated that the greatest risk of perforation
occurred in children being evaluated for possible myocarditis (p 5 0.01) and in those
requiring inotropic support (p , 0.01). Other complications included arrhythmia (5) and
single cases of coronary-cardiac fistula, flail tricuspid leaflet, pneumothorax, hemothorax,
endocardial stripping and seizure.
CONCLUSIONS Risk of endomyocardial biopsy is highest in sick children with suspected myocarditis on
inotropic support. However, EMB can be performed safely with very low morbidity in
pediatric heart transplant recipients. (J Am Coll Cardiol 1999;34:2105–10) © 1999 by the
American College of Cardiology
Endomyocardial biopsy (EMB) has been well-established as
a useful and safe procedure (1). Endomyocardial biopsy has
been utilized in adults for the diagnosis of myocarditis,
adriamycin cardiotoxicity, rejection surveillance in heart
transplant recipients and as an adjunct in diagnosis in other
forms of cardiac disease. In children, EMB has also been
shown to be a useful diagnostic tool for transplant rejection
surveillance (2,3) and in the evaluation of cardiac dysfunc-
tion, unexplained myocardial hypertrophy (3–5), storage or
mitochondrial diseases, unexplained arrhythmia and cardiac
tumors. The morbidity and mortality of EMB has been
reviewed extensively in adults (1,5–7), but there is a paucity
of data on the complications of endomyocardial biopsy in
children.
METHODS
We retrospectively reviewed 1,000 consecutive endomyocar-
dial biopsy procedures performed on pediatric patients (,18
years of age) from July 1987 through March 1996 at
Children’s Hospital of Pittsburgh. Cardiac catheterization
reports were reviewed for patient age at procedure, height,
weight, body surface area, biopsy indication, patient status
(need for inotropic or ventilatory support), vascular access
site, bioptome type and size, biopsy histology, experience of
the operator and procedural complications. Echocardiogram
reports were reviewed for worsening valvar insufficiency or
pericardial effusion. Right or left ventricular biopsies were
obtained either transvenously or transarterially, depending
on the available access site and the ventricle that was to be
biopsied. The bioptomes used included reusable Caves-
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Schultz (5, 5.5, 6, 6.5, 7F) and disposable Cordis (Cordis
Webster Inc., Diamond Bar, California) (5.4, 7F) or Feh-
ling (Fehling Inc., Marietta, Georgia) (5, 5.4, 7F). Approx-
imately five biopsy specimens were obtained at each proce-
dure. All procedures were performed with fluoroscopic
guidance by, or under the direct supervision of, an attending
cardiologist. A short sheath was used when biopsies were
performed from the internal jugular approach. A long
preformed sheath was used and positioned over a wire or
balloon tipped catheter in the right ventricle when biopsies
were performed from the femoral venous approach. The
long sheath was withdrawn slightly as the opened bioptome
was advanced against the endomyocardium. After bioptome
forcep closure, the sheath was readvanced to its original
position and the bioptome was removed. At the end of each
procedure, echocardiography was performed in order to eval-
uate new or changed valvar insufficiency or pericardial effusion.
Patients were reevaluated 2 to 6 h after the procedure and
outpatients were discharged on the day of the procedure.
Significant complications were defined as events attributable to
the biopsy procedure and requiring further therapeutic inter-
vention or an additional period of hospital observation.
Statistical methods. Statistical analysis was performed to
identify patient and procedural variables that were predictive
of a biopsy complication. Outcome variables included all
complications, perforations and arrhythmias. Univariate and
multivariate analysis was performed using S-Plus version 3.3
for Hewlett-Packard (Hewlett Packard Inc., Palo Alto,
California) UNIX machines. Mann-Whitney U test was
used for comparison of continuous variables that did not
conform to a normal distribution. Student t test was used for
continuous variables that were normally distributed. Cate-
gorical variables were compared using chi-square analysis. A
p value ,0.05 was considered significant. Backward step-
wise logistic regression was used for the multivariate anal-
ysis. All significant variables in the univariate analysis were
entered into the multivariate analysis. Significant variables
(p , 0.05) in the multivariate analysis were entered into a
decision-making program. This program (8) maximizes
differences of each significant variable and generates a flow
diagram model that displays subgroups at highest risk of
perforation.
RESULTS
One thousand consecutive EMB procedures were per-
formed on 194 pediatric patients during the study period.
An average of five endomyocardial biopsies was obtained
during each procedure for approximately 5,000 EMB sam-
ples. The mean age at the time of the procedure was 8.6
years (8 days to 18 years), mean weight was 30 kg (2.8 to
127 kg), mean height was 121 cm (48 to 187 cm) and mean
body surface area was 0.98 m2 (0.18 to 2.05 m2). Sixty-four
procedures (6.4%) were performed in infants less than one
year of age. Mean age and weight for this subgroup was 0.46
year and 7.4 kg, respectively.
Indication. Eighty-five percent (846) of the procedures
were performed for transplant rejection surveillance. Fifteen
percent (154) of the procedures were performed to rule out
myocarditis. See Table 1 for a breakdown of the number of
patients and the number of procedures for each subgroup.
Of those with suspected myocarditis, 115 had a dilated
cardiomyopathy with depressed systolic function. Thirty-
eight patients had an unexplained arrhythmia with normal
cardiac function. Additionally, one patient with a multisys-
tem glycogen storage disease underwent a biopsy to assess
possible cardiac involvement.
Operator experience. As part of a teaching institution,
pediatric cardiology fellows participate in a large percentage
of cardiac catheterizations. A biopsy performed by a fellow
was differentiated from a biopsy performed by an attending.
A fellow performed the biopsy under direct supervision of
an attending physician in 457 cases. An attending physician
performed the case without the aid of a fellow in 543 cases.
Each attending physician had significant biopsy experience
prior to this study date. There were 11 complications,
including 3 perforations, when a fellow performed the
biopsy procedure. Twelve complications, including six per-
forations, occurred when an attending physician performed
the procedure. There was no statistical difference in the
complication rates between biopsies performed by fellows
compared with biopsies performed by attending physicians.
There was no difference in attending physician complication
rates, and there was no difference in complication rates in
the first half of the study compared with the latter half.
Biopsy site. The biopsies were performed in the right
ventricle in 986 cases and in the left ventricle in 14 cases.
Biopsies of the left ventricle were done to evaluate isolated
left ventricular dysfunction in 10 cases. One patient with a
heterotopic heart transplant, in whom the allograft right
ventricle was inaccessible, underwent four left ventricular
biopsies from the right femoral artery approach.
Vascular access. Vascular access was obtained through the
right internal jugular vein in 533 (53%), right femoral vein
in 327 (33%), left femoral vein in 92 (9%), left internal
jugular vein in 44 (4%) and right femoral artery in 4 (1%).
Of the 14 left ventricular biopsies, 4 were obtained from the
femoral artery and 10 were obtained through the patent
foramen ovale from the femoral vein.
Patient status. The procedure was considered elective in
965 patients (96%). An elective procedure was defined as a
case in which the patient was hemodynamically stable and
Abbreviations and Acronyms
EMB 5 endomyocardial biopsy
F 5 French (catheter size)
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not reliant upon inotropic, ventilatory or mechanical sup-
port. The remaining 35 procedures were performed on ill
patients receiving intravenous inotropic support alone (9
cases, 1%), ventilation alone (8 cases, 1%) or both intrave-
nous inotropes and ventilation (18 cases, 2%). Patients that
were intubated only for airway protection; usually small
infants were considered elective cases.
Biopsy results. Histology results were divided into five
categories. Severe allograft rejection (grades 3b–4, classified
according to the standardized criteria developed by The
International Society for Heart and Lung Transplantation
[9]) was found in 22 cases (2.6% of biopsies performed for
rejection surveillance). Moderate rejection (grade 2 to 3a)
was found in 193 cases (22.8% of biopsies performed for
transplant rejection surveillance). Acute inflammatory
changes consistent with active myocarditis were seen in 40
cases (26% of biopsies performed for suspected myocarditis).
Nonspecific abnormalities including fibrosis, myocyte hy-
pertrophy and resolving or borderline myocarditis were seen
in 44 cases (28.6% of biopsies performed for suspected
myocarditis). No significant abnormality, including grade 0
to 1 rejection, was seen in 696 cases (69.6% of all biopsies).
This included 70 cases (45.4%) of biopsies performed for
suspected myocarditis and 626 cases (74%) of biopsies for
transplant rejection surveillance.
Cardiac perforation. There was one biopsy-related death,
secondary to perforation of the right ventricular outflow
tract in a two-week-old, 3.6 kg infant with dilated cardio-
myopathy. Resuscitation with immediate pericardiocentesis
and sternotomy was performed but was unsuccessful. There
were nine total perforations for an overall incidence of 0.9%
(Table 2). Eight, including the fatal case, occurred among
the 154 patients being evaluated for possible myocarditis for
a 5.2% incidence. Among infants or young children less
than 10 kg on intravenous inotropic support biopsied for
undiagnosed cardiomyopathy, the incidence of perforation
was 33.3% (5/15 cases). The final perforation occurred in a
patient undergoing heart transplant rejection surveillance (1
of 846) for a 0.1% incidence. This patient did not decom-
Table 2. Complications of Endomyocardial Biopsy
Age WT (kg) ACC IND Status Details
Perforation 19 d 3.6 LFV myo ino/vent pericardiocentesis, surgery, died
15 d 3.6 RFV myo ino/vent pericardiocentesis and surgery in cath lab
5 wk 3.6 LFV myo ino pericardiocentesis and surgery in cath lab
7 wk 3.5 RFV myo ino pericardiocentesis and surgery in cath lab
18 mo 8.3 LFV myo elec pericardial effusion, ICU pericardiocentesis
2.6 yr 10.6 LFV myo elec pericardiocentesis and surgery in cath lab
19 mo 10.0 RFV myo ino pericardiocentesis and surgery in cath lab
5.7 yr 17.2 LFV myo ino sheath through RV free wall, taken to OR
9.2 yr 25.0 RFV TX elec coronary-cardiac fistula, no treatment
Arrhythmia 6 wk 4.2 LFV myo ino bradycardia with sheath across PFO in LV
5 mo 4.7 RFV myo elec asystole with sheath across PFO in LV
7 mo 7.8 RFV myo elec V-FIB with sheath in RV, defibrillation
20 mo 12.8 RFV TX elec atrial arrhythmia with sheath in RV
17.2 yr 81.3 RFV myo elec A-flutter overdrive pacing, cardioversion
Other 15 d 3.5 RFV myo ino/vent LV biopsy, endocardial stripping
12 mo 33 RFV TX elec pneumothorax, chest tube placed in cath lab
16 mo 9.8 RIJ myo elec sheath perforation of RIJ, hemothorax
17 mo 10.6 RIJ TX elec small pneumothorax, oxygen
9.6 yr 21.7 LFV TX elec Moderate TR secondary to ruptured chordae
10 yr 31.1 RIJ TX elec seizure
14 yr 62 RFV myo ino/vent worsening CHF, LV assist device
17.9 yr 72 RFA myo elec LV biopsy, worsening pulmonary edema
18 yr 29.3 RIJ TX elec severe hypertension, resolution with Lasix
ACC 5 vascular access for biopsy; cath 5 catheterization; CHF 5 congestive heart failure; d 5 days; ECHO 5 echocardiogram; elec 5 elective procedure on no inotropic
support; ICU 5 intensive care unit; IND 5 indication for biopsy; ino 5 intravenous inotropic support; LFV 5 left femoral vein; LV 5 left ventricle; mo 5 month; myo 5 rule
out myocarditis; OR 5 operating room; PFO 5 patent foramen ovale; RFA 5 right femoral artery; RIJ 5 right internal jugular vein; RFV 5 right femoral vein; RV 5 right
ventricle; TX 5 transplant rejection surveillance; TR 5 tricuspid regurgitation; vent 5 ventilatory support; V-FIB 5 ventricular fibrillation; wk 5 week; yr 5 year.
Table 1. Patients and Procedures
Cardiomyopathy Transplant Total
Number of patients 123 90 194*
Number of
procedures
154 846 1,000
Mean procedure/
patient
1.3 9.4 5.2
*Nineteen patients underwent EMB as part of evaluation for cardiomyopathy as well
as rejection surveillance after transplantation.
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pensate or require immediate therapeutic intervention. His-
tological exam of the biopsy specimen revealed epicardium
and an epicardial coronary vessel. The patient developed a
loud continuous murmur and small pericardial effusion.
Subsequent angiography (Fig. 1) confirmed the presence of
a coronary artery to right ventricular fistula and aneurysm of
the left anterior descending coronary artery. This patient
remains asymptomatic and has subsequently undergone
further biopsies without complications. Of the other seven
surviving patients with perforation, six required immediate
interventions for hemodynamic compromise associated with
cardiac tamponade. Emergent echocardiography, pericar-
diocentesis and surgery were performed in the catheteriza-
tion laboratory in five cases and in the operating room in
one case. Tamponade was relieved and perforations were
localized and successfully closed. In the remaining case,
hemodynamic compromise did not develop until the patient
was stabilized in the intensive care unit. Pericardiocentesis
without surgery was successful for stabilization. There were
no neurological deficits associated with perforation in the
eight surviving patients.
Significant risk factors for perforation in the univariate
analysis included: younger patient age (p 5 0.001), smaller
size (p , 0.001), nonelective status (p , 0.001), cardiomy-
opathy as an indication for biopsy (p , 0.001) and femoral
approach (p , 0.01). Operator experience, bioptome type
and biopsy histology were not significant variables in the
univariate analysis. Multivariate analysis demonstrated that
the greatest risk of perforation was in children biopsied as
part of the evaluation for myocarditis (p 5 0.01) and in
those requiring inotropic support (p , 0.01). The multi-
variate analysis is graphically displayed using a decision tree
software package (Fig. 2). Maximizing differences in the
significant variables from the multivariate analysis generated
each level of this graph.
Although 577 (58%) of the procedures were performed
from the internal jugular vein, all nine perforations were
from the femoral venous approach (p , 0.01). Perforation
occurred more commonly when the procedure was per-
formed from the left femoral vein (6 of 92) compared with
the right femoral vein approach (4 of 327) (p , 0.01). Site
of vascular access, however, was not found to be a significant
variable in the multivariate analysis.
Arrhythmia. Significant arrhythmia, requiring interven-
tion, occurred in five patients for an incidence of 0.5%
(Table 2). Atrial fibrillation occurred in two patients,
bradycardia with hypotension in one patient and ventricular
fibrillation in two patients. Each arrhythmia was controlled
in the catheterization laboratory with antiarrythmics or by
cardioversion with no adverse outcome. All five of these
arrhythmias occurred during biopsy from the femoral ve-
nous approach and four of the five occurred during manip-
ulation of the catheter or sheath. Also, four of five arrhyth-
mias occurred in patients with dilated cardiomyopathy,
none of whom had biopsy proven myocarditis. Multivariate
analysis demonstrated the greatest risk of arrhythmia oc-
curred in children requiring intravenous inotropic support
(p , 0.01).
Other complications. Two patients undergoing EMB
from the right internal jugular approach required chest tube
placement for pneumothorax and hemothorax. One patient
had worsening tricuspid regurgitation due to an avulsed
chordae tendinae. Endocardial stripping was noted on
echocardiogram after left ventricular biopsy. A mobile
pedunculated echodense strip of endomyocardium was
noted along the left ventricular free wall. It was postulated
that the bioptome stripped the endomyocardium during an
unsuccessful attempt to obtain a biopsy specimen. A gen-
eralized seizure probably related to the use of chlorproma-
Figure 1. Selective left coronary angiogram in the right anterior
oblique view (A) and four chamber view (B), showing diffusely
dilated left anterior descending branch with an aneurysmal dilation
(open arrows) and multiple fistulous communications to the right
ventricle (arrow heads).
Figure 2. Graphic display of statistically significant risk factors for
myocardial perforation with endomyocardial biopsy. The cardio-
myopathy group includes patients with dilated cardiomyopathy
and arrhythmia who were biopsied for suspicion of myocarditis.
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zine hydrochloride occurred in one patient with a previous
history of seizures. Two patients had significant deteriora-
tion of their heart failure. One patient had worsening
pulmonary edema and required aggressive diuresis. Another
patient with dilated cardiomyopathy became hemodynami-
cally unstable and required an intraaortic balloon pump for
stabilization.
Summary of morbidity and mortality. The overall inci-
dence of a serious complication from endomyocardial biopsy
was 19 of 1,000 or 1.9%. Overall perforation rate was 0.9%
and overall mortality was 0.1%. In the evaluation of possible
myocarditis in dilated cardiomyopathy patients or patients
with new onset arrhythmia, the incidence of complication
was 14 of 154 or 9.1%, perforation was 5.2% and mortality
was 0.6%. In patients receiving endomyocardial biopsy for
transplant rejection surveillance, the incidence of serious
complication was 5 of 846 or 0.6%, perforation was 0.1%
and there was no mortality.
DISCUSSION
Incidence of complications. Endomyocardial biopsy re-
mains the standard tool for diagnosis of myocarditis and
allograft rejection. Since Lurie et al. (10) reported their
initial EMB experience in the pediatric age group, there
have been several small series describing complications such
as pneumothorax, hemothorax, dysrhythmia, heart block,
perforation and death. Complication rates vary from none
(3–5,11) to 10.6% (4). This study reflects comparable overall
pediatric EMB complication rates while demonstrating the
relative safety of rejection surveillance EMB compared with
the risk of EMB in small sick patients with suspected
myocarditis.
Risk factors for complications. Technical difficulties de-
scribed in adults are magnified in children. The internal
jugular venous approach has lessened some of these diffi-
culties (12), but percutaneous access from the neck is
technically more demanding in infants. Endomyocardial
biopsy from the groin (13) necessitates a long preformed
outer sheath to properly position the bioptome in the right
ventricle. Proper sheath curvature and placement is crucial
in avoiding trauma to the thin right ventricular outflow
tract. Partial removal of the sheath prior to obtaining each
biopsy will minimize the possibilities of the sheath contrib-
uting to perforation. Biopsy from the internal jugular venous
approach does not require an additional sheath within the
heart.
Statistically significant risk factors for perforation in this
series included inotropic dependency and cardiomyopathy.
It is likely that this reflects the thinner right ventricular wall
in patients with dilated cardiomyopathy. Intrinsic disease of
the myocardium, such as myocarditis, may further weaken
the structural integrity of the ventricular wall, thus increas-
ing the risk of perforation.
In this series, all perforations occurred using the femoral
venous approach with an increased incidence from the left
groin versus the right groin. This finding, however, did not
reach statistical significance in the multivariate analysis and
might merely reflect other factors, such as an increased
failure rate of percutaneous access to the right femoral vein
in the smaller, sicker patients. It might reflect preexisting or
previous lines with thrombosis of the right femoral venous
system. Similarly, the femoral venous approach as compared
with the jugular approach was not found to be a statistically
significant risk factor for perforation in the multivariate
analysis. The higher incidence of perforation in this group
might reflect that the femoral venous approach was often
the operator’s first choice of access in the sickest patients.
Utility of EMB. The clinical utility of EMB for evaluating
patients with possible myocarditis has been debated
(11,13,15). Nevertheless, EMB continues to be widely used
in many centers for the evaluation of possible myocarditis. It
has been shown to be a useful diagnostic as well as
prognostic tool for unexplained cardiac dysfunction (15–
18). While we recognize that the use of corticosteroids,
intravenous gamma globulin and other more potent immu-
nosuppressants have not been studied in randomized con-
trolled trials in the pediatric patient with biopsy proven
myocarditis. Histological confirmation of an inflammatory
cardiomyopathy may alter management of the patient in
other ways. Cardiac dysfunction secondary to active inflam-
mation is frequently reversible with restoration of normal
cardiac function in many pediatric patients (15). As a
cardiac transplant center with extracorporeal membrane
oxgenation support and cardiac assist device capabilities, an
endomyocardial biopsy has proven to be a valuable tool in
the evaluation of the critically ill patient referred for trans-
plantation for new onset cardiomyopathy (18). When in-
flammatory cardiomyopathy is confirmed, transplantation is
deferred until the patient has been given a full chance to
undergo myocardial recovery. This would include, if neces-
sary, a trial of extracorporeal membrane oxgenation support
or left ventricular (or biventricular) assistance. If there was
no evidence of an inflammatory process, then the critically
sick patient with ventricular failure would be considered for
transplantation at the earliest possible time.
Small, sick children with possible myocarditis pose the
most difficult diagnostic dilemmas. While the described
benefits of knowing if a child with acute cardiomyopathy
has myocarditis also apply to the infant population, the risk
of biopsy in the critically sick infant or small child (,10 kg)
appears excessive. Indeed, in this study there was a 33%
incidence of cardiac perforation in this subgroup. In light of
this, we would no longer recommend that this group of
patients undergo endomyocardial biopsy as a routine part of
their evaluation for possible myocarditis.
Summary. Compared with the established risk of EMB in
adults, there is an increased risk in children, especially in
children dependent on inotropes undergoing EMB for the
evaluation of myocarditis. In contrast to patients with
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dilated cardiomyopathy, we, like others (6), have found that
EMB in the evaluation of allograft rejection carries a very
low risk and can be performed with acceptable morbidity
and no mortality.
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